Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1

Inflammation Research

Volumn 50, Issue 3, 2001, Pages 175-182

  Sadowski, T ^a   Steinmeyer, J ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

MMP; PAI 1; Plasminogen activators; Tetracyclines; TIMP 1

Indexed keywords

COLLAGENASE; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; MINOCYCLINE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEOGLYCAN; TETRACYCLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; GENE EXPRESSION; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CATTLE; CELLS, CULTURED; CHONDROCYTES; GENE EXPRESSION REGULATION; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TETRACYCLINES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0035074305     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050742     Document Type: Article

References (51)

1. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
2. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family
3. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilage and in explants of bovine articular cartilage cultured with interleukin-1
4. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan: Evidence for proteolysis at this site in vivo in human articular cartilage
5. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints
6. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: A pivotal role for stromelysin-1 in cartilage destruction
7. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
8. Endogenous activation of latent collagenase by rheumatoid synovial cells
9. Plasmin degradation of cartilage proteoglycan
10. Tissue inhibitors of metalloproteinases: Evolution, structure and function
11. Excess of metalloproteases over tissue inhibitor of metalloproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis
12. Regulation of tissue inhibitor of metalloproteinases-3 by transforming growth factor-beta and dexamethasone in bovine and human articular chondrocytes
13. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
14. The placental type plasminogen activator inhibitor, PAI-2
15. Occurence of interleukin-1 in human synovial fluid: Detection by RIA, bioassay and presence of bioassay-inhibiting factors
16. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage
17. Factors involved in the regulation of proteoglycan metabolism in articular cartilage
18. Influence of interleukin-1 on the morphology and proteoglycan metabolism of cultured bovine articular chondrocytes
19. Minocycline reduces gingival collagenolytic activity during diabetes: Preliminary observations and a proposed new mechanism of action
20. Tetracyclines inhibit connective tissue breakdown: New therapeutic implication for an old family of drugs
21. Long-term doxycycline treatment inhibits histologic and immunologic features of spontaneous osteoarthritis in guinea pigs
22. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline
23. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage
24. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity
25. A nonantibacterial chemically-modified tetracycline inhibits manunalian collagenase activity
26. Transcriptional downregulation of stromelysin by tetracycline
27. Differential patterns of response to doxycycline and transforming growth factor beta 1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes
28. Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads
29. An assay detecting nanogram levels of proteolytic enzymes
30. An assay of collagenase activity using enzyme-linked immunosorbent assay for mammalian collagenase
31. Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1 treated articular cartilage
32. An improved assay for proteases and polysaccharidases employing a cartilage proteoglycan substrate entrapped in polyacrylamide particles
33. Tissue-type plasminogen activator and fast-acting plasminogen activator inhibitor in plasma
34. Angiotensin II regulates the expression of plasminogen activator inhibitor in cultured endothelial cells
35. Clinical pharmacokinetics of doxycycline and minocycline
36. Bioavailability of different brands of tetracycline in undernourished subjects
37. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: Relationship of bone and cartilage degradation
38. Low dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans
39. Inhibition of neutral metalloproteinase activities in epiphysal and articular cartilage by tetracyclines both in vitro and in vivo
40. Pharmacological influence on the collagenolytic activities of articular cartilage
41. Tetracyclines inhibit human synovial collagenase in vivo and in vitro
42. Specificity of inhibition of matrix metalloproteinase activity by doxycycline
43. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline
44. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase-1 (matrix metalloproteinase 1)
45. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenases
46. Comparative immunolocalization studies of collagenase-1 and collagenase-3 production in the rheumtoid lesion, and by human chondrocytes and synoviocytes in vitro
47. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: An immunohistochemical study
48. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases
49. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinase-2
50. A matrix metalloproteinase expressed on the surface of invasive tumour cells
51. Furin-dependent intracellular activation of the human stromelysin-3 zymogen